News
28m
InvestorsHub on MSNMustang Bio Shares Surge After FDA Grants Orphan Drug StatusMustang Bio Inc (NASDAQ:MBIO) stock soared over 78% following the U.S. Food and Drug Administration’s orphan drug designation ...
Investing.com -- Mustang Bio Inc (NASDAQ: MBIO) stock surged over 78% after the U.S. Food and Drug Administration granted orphan drug designation to its MB-101 treatment for recurrent diffuse and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results